Thyroid Cancer Clinical Trials

A listing of Thyroid Cancer medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Arizona

Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Tucson Arizona 85724

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

California

Research Center
Additional Locations California

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

View More ▼

UPDATED

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Los Angeles California 90048

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Los Angeles California 90033

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Los Angeles California 90404

A clinical trial seeking patients for a research study for the treatment of Thyroid Cancer, Advanced Non-hematological Malignancies or HRAS Mutant Tumor

Orange California 92868

A clinical research study of BLU-667 for the treatment of Lung Cancer, Nonsmall Cell, Thyroid Cancer or Solid Tumor

Palo Alto California 94304

Patients are needed to participate in a clinical research study evaluating MGD009

UPDATED

San Francisco California 94143-1711

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

San Francisco California 94143

Patients are needed to participate in a clinical research study evaluating MGD009

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Connecticut

Research Center
Additional Locations Connecticut

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

District of Columbia

Washington District of Columbia

Patients are needed to participate in a clinical research study evaluating Lenvatinib and Lenvatinib matching placebo for the treatment of Thyroid Cancer

Washington District of Columbia 20007

Patients are needed to participate in a clinical research study evaluating MGD009

Florida

UPDATED

Orlando Florida 32806

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Sarasota Florida 34239

Patients are needed to participate in a clinical research study to evaluate Thyroid Cancer, Thyroid Nodules, Thyroid Adenoma or Thyroiditis

UPDATED

Tampa Florida 33612

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Georgia

Research Center
Additional Locations Georgia

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

View More ▼

UPDATED

Atlanta Georgia 30303

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Illinois

UPDATED

Chicago Illinois 60637

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Chicago Illinois 60637

Patients are needed to participate in a clinical research study evaluating LOXO-292 for the treatment of Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer or Solid Tumor

Indiana

UPDATED

Indianapolis Indiana 46202

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Iowa

Iowa City Iowa 52242

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

Maryland

UPDATED

Baltimore Maryland 21231

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Bethesda Maryland 20889

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Rockville Maryland 20850

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

Massachusetts

Research Center
Additional Locations Massachusetts

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

View More ▼

Boston Massachusetts 02114

A clinical research study of BLU-667 for the treatment of Lung Cancer, Nonsmall Cell, Thyroid Cancer or Solid Tumor

Boston Massachusetts 02115

A clinical research study of MLN0128 for the treatment of Anaplastic Thyroid Cancer or Thyroid Cancer, Metastatic

UPDATED

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Boston Massachusetts 02215

A clinical trial seeking patients for a research study for the treatment of Thyroid Cancer, Advanced Non-hematological Malignancies or HRAS Mutant Tumor

Boston Massachusetts 02215

A Phase 1/Phase 2 clinical study for patients with ALK-positive Non-small Cell Lung Cancer (NSCLC), RET-positive Non-small Cell Lung Cancer (NSCLC) or RET-positive Thyroid Cancer

Boston Massachusetts 02115

A Phase 1/Phase 2 clinical study for patients with ALK-positive Non-small Cell Lung Cancer (NSCLC), RET-positive Non-small Cell Lung Cancer (NSCLC) or RET-positive Thyroid Cancer

Boston Massachusetts 02115

A Phase 2 clinical study for patients with Thyroid Cancer

UPDATED

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating LOXO-292 for the treatment of Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer or Solid Tumor

UPDATED

Boston Massachusetts 02115

Patients are needed to participate in a clinical research study evaluating LOXO-292 for the treatment of Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer or Solid Tumor

Boston Massachusetts 02114

Patients are needed to participate in a clinical research study evaluating MGD009

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study evaluating MGD009

UPDATED

Boston Massachusetts 02215

Patients are needed to participate in a clinical research study of Nivolumab and Ipilimumab to evaluate Thyroid Cancer

Michigan

Research Center
Additional Locations Michigan

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

View More ▼

Detroit Michigan 48202-268

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza

UPDATED

Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study evaluating LOXO-292 for the treatment of Non-Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer or Solid Tumor

Minnesota

UPDATED

Rochester Minnesota 55905

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

UPDATED

Rochester Minnesota 55902

A clinical trial seeking patients for a research study for the treatment of Thyroid Cancer, Advanced Non-hematological Malignancies or HRAS Mutant Tumor

Missouri

Research Center
Additional Locations Missouri

A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer

New Jersey

UPDATED

New Brunswick New Jersey 08903

A clinical trial seeking patients for a research study for the treatment of Advanced Cancer (MK-3475-158/KEYNOTE-158)

New Brunswick New Jersey 08903

Patients are needed to participate in a clinical research study evaluating CC-486 (Oral Azacitidine) and Vidaza